RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:254449

Atrophic lichen planus

high confidenceDisorder

Also known as: Atrophic LP

Publications

175

63.9th percentile

Trials

1

Interventional, condition-specific

Researchers

567

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

A rare variant of cutaneous lichen planus characterized by the development of pale papules or plaques with an atrophic center.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

atrophic LP

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    175 matched papers (86 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPresent

    1 matched on ClinicalTrials.gov (1 recruiting in sample)

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

175

175 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

175 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

86 in the last 10 years · high confidence · 63.9th percentile (publications denominator)

Phrase hits: 175 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

567

Distinct author names in 175 sampled papers — named people below.

Who's working on it?

People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.

  1. 01
    Agha-Hosseini F3 papers · 2023

    Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

    Papers in Europe PMC
  2. 02
    Bieber K3 papers · 2023

    Lübeck Institute of Experimental Dermatology and Center for Research on Inflammation of the Skin, University of Lübeck, Lübeck, Germany.

    Papers in Europe PMC
  3. 03
    Dore SE3 papers · 1923
    Papers in Europe PMC
  4. 04
    Ludwig RJ3 papers · 2023

    Department of Dermatology, University of Lübeck, Lübeck, Germany.

    Papers in Europe PMC
  5. 05
    Maccormac H3 papers · 1938
    Papers in Europe PMC
  6. 06
    Pakfetrat A3 papers · 2024

    Professor, Department of Oral Medicine, Oral and Maxillofacial Diseases Research Center, School of Dentistry, Mashhad University of Medical Sciences , Mashhad, Iran .

    Papers in Europe PMC
  7. 07
    Sharma A3 papers · 2023

    Biochemistry All India Institute of Medical Sciences New Delhi India.

    Papers in Europe PMC
  8. 08
    Aghaee-Bakhtiari SH2 papers · 2024

    Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

    Papers in Europe PMC
  9. 09
    Bardazzi F2 papers · 2025

    Dermatology Unit, IRCCS Azienda-Ospedaliero Universitaria di Bologna, 33-40126 Bologna, Italy.

    Papers in Europe PMC
  10. 10
    Boch K2 papers · 2022

    Department of Dermatology, University of Lübeck, Lübeck, Germany.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

1

interventional trials for this specific condition

1 interventional trial matched this specific condition name; 1 currently recruiting in our sample. 142 trials are registered for lichen planus, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

1 interventional trial — more than 73% of diseases in the trials denominator have none at all (5114 of 7003; this disease is at the 76.8th percentile).

high confidence · 76.8th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

1 interventional trials matched after quoted-phrase search and title/condition post-filter.

Broader category: lichen planus

142

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Atrophic lichen planus" OR "Atrophic LP"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Atrophic lichen planus" OR "Atrophic LP"

Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).

Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"lichen planus"

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T11:03:14.991Z